NOTRELOAD AI
  • NOTRELOAD AI
  • Stocks BUZZ.
  • #TrumpTrade
  • 24-HOUR Pass →
  • Invest ↗
Sign in Subscribe

Atomera Shares Plunge After STMicroelectronics Ends MST Project

Atomera stock drops 34% to a 52-week low after STMicroelectronics decided not to use its Mears Silicon Technology (MST) in upcoming products.

Atomera Shares Plunge After STMicroelectronics Ends MST Project
Credit: Atomera
Already have an account? Sign in.
10/22/2025 · 2:37 PM
ATOM
/ Read more

Feed↓

BofA Turns Bearish on Qualcomm: Underperform Rating & $145 Target Amid Apple Exit Risks
Featured/ 03/10/2026 · 7:15 AM

BofA Turns Bearish on Qualcomm: Underperform Rating & $145 Target Amid Apple Exit Risks

Bank of America downgrades Qualcomm to Underperform with a $145 price target, highlighting the looming loss of Apple business and slow future growth in this mature chip market.

/ Subscriber only
SolarEdge Back on Top – BofA Upgrades Stock After U.S. Market Share Win
03/10/2026 · 7:00 AM

SolarEdge Back on Top – BofA Upgrades Stock After U.S. Market Share Win

BofA upgrades SolarEdge (SEDG) to Neutral from Underperform, raising the price target to $40 from $17, citing stabilized margins, revenue, liquidity, and regained U.S. inverter market leadership.

/ Subscriber only
Mineralys Shares Fall After FDA Accepts NDA for Lorundrostat – Explore-OSA Misses Primary Endpoint but Delivers Strong BP Reduction
03/09/2026 · 5:57 PM

Mineralys Shares Fall After FDA Accepts NDA for Lorundrostat – Explore-OSA Misses Primary Endpoint but Delivers Strong BP Reduction

Mineralys receives FDA acceptance of NDA for lorundrostat for hypertension. PDUFA target date: December 22, 2026. Explore-OSA missed primary endpoint but demonstrated meaningful BP reduction.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe